Cancer statistics, 2010
2010
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988–2006
10.1016/j.eururo.2010.10.003 · 2011
Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: a comparative study of low and high doses
10.1667/rr3354 · 2005
Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation
10.1038/sj.onc.1206680 · 2003
Differential responses of stress genes to low dose-rate γ irradiation
2003
Fractionated radiation therapy can induce a molecular profile for therapeutic targeting
10.1667/rr2105.1 · 2010
Clinical implications of the p53 tumor-suppressor gene
10.1056/nejm199310283291807 · 1993
p53, guardian of the genome
10.1038/358015a0 · 1992
p53 in health and disease
10.1038/nrm2147 · 2007
p53 function and dysfunction
10.1016/0092-8674(92)90421-8 · 1992
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
10.1016/0092-8674(93)90719-7 · 1993
p53 status and the efficacy of cancer therapy in vivo
10.1126/science.7973635 · 1994
Wild-type p53 is a cell cycle checkpoint determinant following irradiation
10.1073/pnas.89.16.7491 · 1992
Tumor-suppressor p53: implications for tumor development and prognosis
10.1200/jco.1998.16.9.3158 · 1998
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
1988
The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line
10.1016/s0027-5107(96)00193-5 · 1997
Surfing the p53 network
10.1038/35042675 · 2000
The hypoxic inducible stress response as a target for cancer drug discovery
10.1053/j.seminoncol.2006.04.011 · 2006
Regulation of DNA repair in hypoxic cancer cells
10.1007/s10555-007-9061-3 · 2007
Hypoxic regulation of mRNA expression
10.4161/cc.7.13.6203 · 2008
Hypoxia induces a novel signature of chromatin modifications and global repression of transcription
10.1016/j.mrfmmm.2008.01.001 · 2008
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation
10.1158/0008-5472.can-06-4250 · 2007
Microarray analysis of radiation response genes in primary human fibroblasts
10.1016/j.ijrobp.2006.08.004 · 2006
Gene expression profiles in human lymphocytes irradiated in vitro with low doses of gamma rays
10.1667/rr0487.1 · 2007
Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts
10.1016/j.ijrobp.2005.08.030 · 2006
Low-dose exposure to gamma rays induces specific gene regulations in normal human keratinocytes
10.1667/rr3391 · 2005
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
1991
NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells
10.1158/1535-7163.mct-08-0928 · 2009
Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells
10.1667/rr2703.1 · 2012
Dose- and time-dependent changes in gene expression in human glioma cells after low radiation doses
10.1667/rr0940.1 · 2007
The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity
10.1158/0008-5472.can-10-2820 · 2011
Synergistic antitumor activity of immune strategies combined with radiation
10.2741/2436 · 2007
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy
10.1158/1541-7786.mcr-12-0492 · 2013
Hyper-fractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study
10.1016/0360-3016(95)02202-3 · 1996
Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy
10.1016/j.radonc.2004.12.019 · 2005
Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm
10.1016/j.ijrobp.2003.09.019 · 2004
Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm
10.1016/j.ijrobp.2006.11.045 · 2007
Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group
10.1016/j.ygyno.2010.10.018 · 2011
Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status
10.1080/02841860601080407 · 2007
P53 abnormalities and outcomes in colorectal cancer: a systematic review
10.1038/sj.bjc.6602358 · 2005
